Will Australia follow the U.S. lead and sell CBD?

3y
3m read
Summary

Product types have also been limited to oral, oral mucosal and sublingual formulations, dismissing other common delivery types such as vapes and topical creams. / Photo: Memedozaslan / iStock / Getty Images Plus Product types have also been limited to oral, oral mucosal and sublingual formulations, dismissing other common delivery types such as vapes and topical creams. The government is expected to make a final decision on OTC low-dose CBD on Nov. 25. The Australian government made an interim decision on Sept. 9 to make low-dose CBD medication an over-the-counter (OTC) option. Said Dr Mark Hardy of CA Clinics, the country’s first and largest medicinal cannabis network: “This is a welcome move, but it’s important to note that the effects of low-dose CBD may be negligible for many patients. However, the recent government announcement means CBD could be labelled as a Schedule 4 drug, instead of Schedule 3 drug, with implementation proposed on June 1, 2021.

Article Preview

Australians might be looking at a cleared path to cannabis medications as soon as next year.

The Australian government made an interim decision on Sept. 9 to make low-dose CBD medication an over-the-counter (OTC) option.

Right now, accessing treatments Down Under means negotiating pathways to obtain a doctor’s prescription and approvals from the government’s Therapeutic Goods Administration (TGA), the Aussie version of the U.S. Food and Drug Administration. However, the recent government announcement means CBD could be labelled as a Schedule 4 drug, instead of Schedule 3 drug, with implementation...

Read the full article @ The Growth Op